Phenserine - Next Generation AChE Inhibitor for Alzheimer's Disease (AD)
Key Data:
Drug (brand / generic)
Phenserine
Company / licensee
Axonyx
Therapy class
AChE inhibitor
Product description
Dual-acting AChE inhibitor and anti-amyloid agent
Current indication
Alzheimer's disease
Market sector
CNS
Development status
Phase II / III
